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_______________________________________________________________________________ 
Background: Structural characterization of integral-
membrane (IM) metallopeptidases (MPs) faces enormous 
technical hurdles. 
Results: We have discovered a novel family of minimal 
MPs, minigluzincins, and determined the crystal structures 
of the zymogens of two family members. 
Conclusion: Minigluzincins are valid models for catalytic 
domains of M48- and M56-family IMMPs. 
Significance: They provide a high-resolution scaffold for 
the design of small-molecule inhibitors of IMMPs. 
 
SUMMARY 
 
In the search for structural models of integral-
membrane metallopeptidases (MPs), we discovered 
three related proteins from thermophilic prokaryotes, 
which we grouped into a novel family called 
“minigluzincins”. We determined the crystal structures 
of the zymogens of two of these (Pyrococcus abyssi 
proabylysin and Methanocaldococcus jannaschii 
projannalysin) which are soluble and, with ~100 
residues, constitute the shortest structurally 
characterized MPs to date. Despite relevant sequence 
and structural similarity, the structures revealed two 
unique mechanisms of latency maintenance through the 
C-terminal segments hitherto unseen in MPs: intra-
molecular, through an extended tail, in proabylysin, 
and crosswise inter-molecular, through a helix swap, in 
projannalysin. In addition, structural and sequence 
comparisons, as well as phylogenetic and 
bioinformatics analyses, revealed large similarity with 
MPs of the gluzincin tribe such as thermolysin, 
leukotriene A4 hydrolase relatives, and cowrins. 
Interestingly, gluzincins mostly have a glutamate as 
third characteristic zinc ligand while minigluzincins 
have a histidine. Sequence and structure similarity 
further allowed us to ascertain that minigluzincins are 
very similar to the catalytic domains of integral-
membrane MPs of MEROPS database families M48 
and M56, such as FACE1, HtpX, Oma1, and 
BlaR1/MecR1, which are provided with trans-
membrane helices flanking or inserted into  a 
minigluzincin-like catalytic domain. In a time where 
structural biochemistry of integral-membrane proteins 
in general still faces formidable challenges, the 
minigluzincin soluble minimal scaffold may contribute 
to our understanding of the working mechanisms of 
these membrane MPs and to the design of novel 
inhibitors through structure-aided rational drug design 
approaches. 
The plasma membrane is the key information 
interface between the cytosol and cellular compartments or 
the extracellular environment, and whole genome analyses 
have revealed that 20-30% of proteins in humans, bacteria 
and fungi are polytopic integral-membrane (IM) proteins 
(1-4). They are of vital importance to living cells through 
their key roles in communication and transport, which 
explains why more than 60% of current pharmaceutical 
drug targets are membrane proteins (5,6). Among IM 
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proteins are members of the peptidase class of enzymes, 
including integral-membrane metallopeptidases (IMMPs) 
from families M48 and M56 (according to the MEROPS 
database, http://merops.sanger.ac.uk; (7)), which are α-
helical for their transmembrane parts, as found in the 
otherwise unrelated rhodopsins, transporters, and channels 
(8). 
M48 metallopeptidases (MPs) are subdivided into 
M48A, M48B, and M48C, whose prototypes are, 
respectively, Saccharomyces cerevisiae Ste24p, 
Escherichia coli HtpX, and human mitochondrial Oma1 
peptidase. Ste24p was discovered as an enzyme required 
for maturation of the mating pheromone a-factor in yeast 
(9). Its mammalian ortholog, farnesylated-protein 
converting enzyme 1 (FACE1 alias Zmpste24), performs a 
critical cleavage that removes the hydrophobic farnesyl-
modified tail of prelamin A (10). Knockout mice show 
growth retardation, muscular dystrophy, and premature 
death; similarly, disruptive mutations in humans have 
drastic consequences for health and lifespan (11-13). 
HtpX, together with the ATP-dependent protein FtsH, 
participates in the quality control system of bacterial 
membrane proteins, which is essential for growth and 
survival of the cell (14-17). Failure of this system under 
environmental stress conditions leads to the accumulation 
of misfolded membrane proteins. Finally, Oma1 helps in 
maintaining the integrity of the mitochondrial inner 
membrane (18,19). It plays a crucial role in the proteolytic 
inactivation of the dynamin-related GTPase Opa1, and its 
loss causes obesity and defective thermogenesis in mice 
(20). Family M56, in turn, includes BlaR1 from 
Staphylococcus aureus and Bacillus licheniformis, and 
MecR1 from S. aureus. They function as parts of the 
signal-transduction systems that trigger bacterial resistance 
to β-lactam antibiotics, a phenomenon that poses a serious 
threat to animal and human health and is exerted through 
the synthesis of a β-lactamase or a penicillin-binding 
protein (21-28). BlaR1 and MecR1 are composed of an N-
terminal IMMP domain facing the cytosol and a C-
terminal extracellular sensor domain that binds 
environmental β-lactams (29-32). 
The strategic and widespread biological relevance 
of IMMPs underpins the need to acquire detailed 
knowledge about them at the molecular level, and atomic 
structural information, as provided by X-ray diffraction or 
nuclear magnetic resonance, makes a major contribution to 
this type of knowledge (33,34). However, structural 
biochemistry of IM proteins in general faces formidable 
conceptual and technical challenges due to the low 
concentrations at which they are naturally present in 
organisms, the difficulty in finding adequate recombinant 
overexpression systems that yield sufficient amounts of 
native-like protein, and their insolubility in strictly aqueous 
media, which requires screening for detergents and lipids 
that mimic the native membrane environment (35). 
Consequently, the only IMMP structures published to date 
are those of the intra-membrane site-2 protease (S2P; (36)) 
from the hyperthermophylic archaeon 
Methanocaldococcus jannaschii (MEROPS family M50), 
an ortholog of a human enzyme that releases the N-
terminal transcription factor domain from membrane-
bound sterol regulatory element binding proteins (36-38) 
and is unrelated to M48 and M56 IMMPs, and of human 
and yeast FACE1/Ste24p (Protein Data Bank [PDB] access 
codes 4AW6 and 4IL3; (39,40)), the only functional, truly 
integral-membrane representatives of these two latter 
families. In such a scenario, strategies aimed at obtaining 
high-resolution structural information on soluble, 
correctly-folded fragments of IMMP target proteins, such 
as globular catalytic domains (CDs) inserted into the 
overall transmembrane scaffold, may prove helpful in both 
the study of catalytic mechanisms and the design of drug-
like inhibitors. The presence in the amino-acid sequence of 
M48 and M56 IMMPs of large segments encompassing a 
zinc-binding motif (HEXXH) characteristic of the 
gluzincin and metzincin clans of the zincin tribe of MPs 
(see (41-43) and Fig. 2 in (44)) between transmembrane 
helices (TMHs) provides a useful starting point for the 
identification of such CDs, which are mostly cytoplasmic 
(Fig. 1): in Ste24p and FACE1, these lie between the fifth 
and sixth of their seven TMHs; in HtpX, between the 
second and third of its four putative TMHs; and in 
BlaR1/MecR1, between the third and fourth of their four 
possible IMMP TMHs (26). By contrast, Oma1 is 
predicted to have only two transmembrane segments 
according to bioinformatics approaches (Fig. 1), but this 
topology and the localization of the active site still remain 
controversial (18). 
In this work, we aimed to study the fold of CDs of 
M48 and M56 IMMPs to provide insights into the minimal 
scaffold required for their activity. As extensive expression 
trials of the putative CDs of several members of both 
families failed (our unpublished results), we set about 
searching for uncharacterized standalone hypothetic 
proteins with significant sequence similarity to these CDs 
using various bioinformatics approaches. We identified, 
cloned, and overexpressed three sequences from the 
archaeal thermophyles Pyrococcus abyssi and M. 
jannaschii, and the thermophilic bacterium Aquifex 
aeolicus. We further purified and crystallized the first two, 
determined and analyzed their crystal structures, and 
functionally verified their zymogenic forms. Finally, we 
validated their suitability as valuable structural models for 
the CDs of M48 and M56 IMMPs. 
 
EXPERIMENTAL PROCEDURES 
 
Bioinformatics sequence analyses — A search 
with a partial sequence of M56-family BlaR1 from S. 
aureus (residues K133-L250; UniProt [UP] sequence 
database access code P18357) and MecR1 (L139-L253; 
UP P0A0A9), putatively encompassing their TMH-flanked 
CDs, was carried out in 2004 using ProDom protein 
domain family database (release 2004.1 at 
http://prodes.tolouse.inra.fr), and identified ProDom family 
PD020519 as containing this sequence stretch. This family 
comprised several BlaR1/MecR1-type sequences—and 
others annotated as related to E. coli HtpX—that had been 
built using the PSI-BLAST program (45) with UP Q57587 
(annotated as archaeal uncharacterized protein MJ0123 
from the thermoautotrophican archaeon M. jannaschii; 
hereafter referred to as projannalysin) as the query. In 
contrast to multi-domain BlaR1/MecR1 relatives, UP 
Q57587 included only domain PD020519 and spanned 110 
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residues. Further single-domain hit sequences were the 
uncharacterized proteins UP Q9V1Y2 from the 
thermoautotrophican archaeon P. abyssi (105 residues; 
hereafter proabylysin) and UP O66407 from the bacterial 
thermophile A. aeolicus (110 residues). In the current 
release of ProDom (2010.1; http://prodom.prabi.fr), former 
family PD020519 has expanded dramatically, which has 
led to the three archaeal sequences being currently grouped 
into a separate family, PDB0S8B5, which also includes 
three additional sequences 
(http://prodom.prabi.fr/prodom/current/cgi-
bin/request.pl?db_ent1=PDB0S8B5&wanted=align&SSID 
=363090958_11162).   
The MEROPS database (release 9.7, as of 11/2012) 
was downloaded and used for a sequence-based search 
using PSI-BLAST. Starting with the three aforementioned 
sequences, the top 20 hits were selected (with PSI-BLAST 
E-values ≤ 0.005) for each search, resulting in a total of 69 
unique homologous sequences. A multiple sequence 
alignment of all the sequences selected was obtained using 
the PHYLEMON2 server (46). A final consensus multiple 
sequence alignment was trimmed using the TRIMAl 
method (47) and subsequently used for searching the most 
likely model following the PROTEST methodology (48). 
BLOSUM62 was the used as input model by PHYML (49) 
to build a phylogenetic tree, which was then represented 
using the FIGTREE program 
(http://tree.bio.ed.ac.uk/software/figtree/). Sequence-based 
predictions of regular secondary structure elements were 
performed with JPRED3 
(http://www.compbio.dundee.ac.uk/jpred; (50)). 
Protein production and purification — Synthetic 
genes coding for the A. aeolicus protein (which contained a 
lysine-to-alanine mutation at position 2 due to the cloning 
strategy), proabylysin (lysine-to-valine mutation at 
position 2), and projannalysin (lysine-to-alanine mutation 
at position 2) were purchased from GeneArt (Invitrogen) 
and cloned into vectors pCRI7 and pCRI8 (both modified 
from pET-28a (Novagen) which confers resistance to 
kanamycin) using NcoI and XhoI restriction sites. While 
pCRI7 does not append any extra residue to the protein of 
interest, vector pCRI8 attaches an N-terminal 
hexahistidine-tag followed by a tobacco-etch-virus (TEV) 
protease recognition site. C-terminal deletion mutants 
lacking one to five residues of proabylysin were cloned 
into vector pCRI7, and a C-terminal deletion mutant 
lacking five residues of projannalysin was cloned into 
vector pCRI8. In addition, the genes coding for 
proabylysin and its aforementioned C-terminal deletion 
mutants were cloned into vector pCRI6 (derived from 
plasmid pETM30, which confers resistance to kanamycin), 
which attaches an N-terminal hexahistidine-tag followed 
by glutathione-S-transferase (GST) and a TEV protease 
recognition site, and into a variant of vector pCRI7, into 
which an extra N-terminal streptavidin-tag was introduced 
by PCR (hereafter referred to as vector pCRI7s). All 
constructs were verified by DNA sequencing. Proteins 
were produced by heterologous overexpression in E. coli 
BL21 (DE3) cells, which were grown at 37°C in Luria 
Bertani medium supplemented with 30µg/ml kanamycin. 
Cultures were induced at an OD600 of 0.8 with 0.2-1mM 
isopropyl-β-D-thiogalactopyranoside and kept growing 
either for 5h at 37°C or overnight at 18°C.  
The purification of proabylysin (cloned into the 
pCRI7 vector) was performed as follows: After 
centrifugation at 7,000xg for 30min at 4°C, the cell pellet 
was washed twice with buffer A (50mM Tris-HCl, 500mM 
NaCl, pH8.0), and resuspended in the same buffer 
supplemented with EDTA-free protease inhibitor cocktail 
tablets (Roche Diagnostics) and DNase I (Roche 
Diagnostics). Cells were lysed at 4ºC using a cell disrupter 
(Constant Systems) at a pressure of 1.35Kbar, and the cell 
debris was removed by centrifugation at 50,000xg for 1h at 
4°C. The supernatant was incubated for 1h at 85°C and the 
precipitated material removed by further centrifugation at 
50,000xg for 1h at 4°C. The supernatant was filtered 
(0.22µm pore size; Millipore) and dialyzed overnight at 
room temperature against buffer B (20mM Tris-HCl, 
pH8.0). The protein was subsequently purified by anion 
exchange chromatography using a HiLoad 16/10 Q 
Sepharose HP column followed by a MonoQ 4.6/100PE 
column (both from GE Healthcare), and finally polished 
with a HiLoad 16/60 Superdex 75 size-exclusion-
chromatography column (GE Healthcare) previously 
equilibrated with buffer C (20mM Tris-HCl, 150mM NaCl, 
pH7.4). The purification of the proabylysin C-terminal 
deletion mutants was carried out in the same way except 
that the supernatant was incubated for 1h at 50-65°C 
instead of 85ºC. The purification of proabylysin and its 
mutants with an N-terminal GST fusion protein or a 
streptavidin-tag (encoded by vectors pCRI6 or pCRI7s 
vector, respectively, see above) was also performed in the 
same way except that the heat-shock step was replaced by 
affinity chromatography purification on a GSTrap HP (GE 
Healthcare) or Strep-Tactin Sepharose (IBA) column, 
respectively, according to the manufacturers’ instructions. 
The purification of projannalysin and its C-terminal 
deletion mutant (both cloned into the pCRI8 vector) was 
performed as follows: After centrifugation at 7,000xg for 
30min at 4°C, the pellet was washed twice with buffer A, 
resuspended in the same buffer plus 10mM imidazole, and 
supplemented with EDTA-free protease inhibitor cocktail 
tablets and DNase I (both Roche Diagnostics). Cells were 
lysed using a cell disrupter as described above, and the cell 
debris was removed by centrifugation at 50,000xg for 1h at 
4°C. The supernatant was filtered, incubated with nickel-
nitrilotriacetic acid resin (Invitrogen) previously 
equilibrated with buffer A plus 10mM imidazole, and the 
fusion protein was eluted using buffer A plus 350mM 
imidazole. The sample was then dialyzed overnight at 
20°C against buffer D (50mM Tris-HCl, 250mM NaCl, 
1mM dithiothreitol, pH8.0) in the presence of 
hexahistidine-tagged TEV protease at an enzyme:substrate 
ratio of 1:50 (w/w). Cleavage left the dipeptide glycine-
proline at the N-terminus of both proteins. Digested 
samples were passed several times through nickel-
nitrilotriacetic acid resin previously equilibrated with 
buffer A plus 10mM imidazole to remove non-cleaved 
hexahistidine-containing molecules. Flow-throughs were 
collected, concentrated by ultrafiltration, and further 
purified by size-exclusion chromatography on a HiLoad 
16/60 Superdex 75 column previously equilibrated with 
buffer C.  
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Protein identity and purity were assessed by mass 
spectrometry and 15% Tricine-SDS-PAGE stained with 
Coomassie blue. Ultrafiltration steps were performed with 
Vivaspin 15 and Vivaspin 500 filter devices of 5-KDa cut-
off (Sartorius Stedim Biotech). Protein concentration was 
determined by measuring the absorbance at 280nm using a 
spectrophotometer (NanoDrop) and calculated absorption 
coefficients Ε0.1% of 0.98 and 0.34 for proabylysin and 
projannalysin, respectively. N-terminal sequencing through 
Edman degradation, peptide mass fingerprinting of tryptic 
protein digests, and mass spectrometry analyses were 
carried out at the proteomics facilities of the Centro de 
Investigaciones Biológicas 
(http://www.cib.csic.es/en/servicio.php?iddepartamento=2
7) and Vall d’Hebron Institute of Oncology 
(http://www.vhio.net/research/proteomics/en_index.html). 
Melting temperatures (Tm) through differential scanning 
fluorimetry (thermofluor) were determined by using Sypro 
Orange dye (Life technologies, Invitrogen) and an iCycler 
iQ Real Time PCR Detection system (Bio-Rad) as 
published previously (51,52). Limited-proteolysis trials to 
remove C-terminal peptides from full-length proabylysin 
and projannalysin were undertaken in buffer C by 
overnight incubation at 37°C or 80°C with trypsin, 
subtilisin, thermolysin (all from Sigma), or ulilysin 
(produced in-house according to (53)) at different 
peptidase:substrate ratios (1:1, 1:5, 1:20, 1:50, 1:100, 
1:200, 1:500 (w/w)), and monitored by mass spectrometry. 
Proteolytic and inhibitory activity assays — 
Proteolytic activities were assayed at 37°C in buffer E 
(50mM MES, 150mM NaCl, pH 5.5), buffer F (50mM 
HEPES, 150mM NaCl, pH 7.5) or buffer G (50mM CHES, 
150mM NaCl, pH 9.5) at a final protein concentration of 
50µg/ml for proabylysin and projannalysin, unless 
otherwise stated.  
Proteolytic activity against the fluorescein 
conjugates BODIPY FL casein, DQ gelatin, and DQ BSA 
(all from Invitrogen) was tested according to the 
manufacturer’s instructions using a microplate fluorimeter 
(FLx800, BioTek or Infinite M200, Tecan). Assays with 
natural protein substrates (at 0.25 or 0.50mg/ml) included 
bovine plasma fibronectin, bovine muscle actin, human 
plasma fibrinogen, cold-water fish-skin gelatin, bovine 
milk casein, and bovine milk α-casein (all from Sigma). 
Reactions were carried out in buffer F at 37°C, 65°C, and 
80°C overnight and at an enzyme:substrate ratio of 1/5 
(w/w) for the first two substrates and 1/10 (w/w) for the 
others. Cleavage was assessed by 15% Tricine-SDS-PAGE 
stained with Coomassie blue. Proteolytic activity was 
further tested on eleven fluorogenic substrates of sequence: 
Abz-K-D-E-S-Y-R-K(dnp) (Abz, aminobenzoyl; dnp, 2,4-
dinitrophenylamino), Abz-T-V-L-E-R-S-K(dnp), Abz-D-
Y-V-A-S-E-K(dnp), Abz-Y-G-K-R-V-F-K(dnp), Abz-V-
K-F-Y-D-I-K(dnp), Dabcyl-L-A-R-V-E-Edans (Dabcyl, p-
dimethyl(aminophenyl)azobenzoate; Edans, 2-
aminoethylamino-1-naphthalene sulfonate), Abz-G-I-V-R-
A-K(dnp) (Bachem), Mca-P-L-G-L-Dap(dnp)-A-R-NH2 
(Mca, 7-methoxycoumarin-4-acetyl; Dap, L-
diaminopropionyl) (Bachem), Mca-R-P-K-R-V-E-Nva-W-
R-K(dnp)-NH2 (Nva, norvaline) (Bachem), and Dnp-P-L-
G-L-W-A-(D)R-NH2 (Bachem) (see Ref. (54) for details 
on the first six substrates). Reactions were performed at 
enzyme:substrate molar ratios of 1/0.25, 1/0.5, 1/1.25, 
and 1/6.25 and monitored in a microplate fluorimeter 
(Infinite M200, Tecan). In addition, proteolytic assays with 
DQ BSA and the fluorogenic peptides were performed at 
enzyme:substrate molar ratios of 1/0.1 and 1/0,5, 
respectively, as described above at high temperatures (up 
to 80°C), or in the presence of 0-4M urea or 0-4M 
guanidinium hydrochloride.  
Esterase activity against the chromogenic substrates 
A-ONp (ONp, p-nitrophenyl ester), H-ONp, and L-ONp 
(all from Bachem), and carboxypeptidase activity against 
the chromogenic substrates N-(3-[2-furyl]acryloyl)-F-F-
OH (Bachem), N-(3-[2-furyl]acryloyl)-G-L-A-OH 
(Bachem), and N-(3-[2-furyl]acryloyl)-L-G-P-A-OH 
(Sigma) were tested using a microplate spectrophotometer 
(PowerWave XS, BioTek) at enzyme:substrate molar ratios 
of 1/25 and 1/125 for ester substrates and 1/25 for 
carboxypeptidase substrates. Finally, aminopeptidase 
activity was assayed with fluorogenic substrates F-Amc 
(Amc, 7-amino-4-methylcoumarin), (H)T-Amc, and Y-
Amc (all from Bachem), and with the chromogenic p-
nitroanilide (pNA) derivatives of a representative set of 
natural L-amino acids and peptides (from Bachem): A-
pNA, M-pNA, L-pNA, K-pNA, V-pNA, (H)I-pNA, (H)G-
pNA, N-Acetyl-F-pNA, A-A-pNA, N-benzyloxycarbonyl-
V-G-R-pNA, N(α)-benzoyl-I-E-G-R-pNA, and N-succinyl-
A-A-P-F-pNA. Reactions were monitored in a microplate 
fluorimeter (FLx800, BioTek) or PowerWave XS 
spectrophotometer (BioTek) at enzyme:substrate molar 
ratios of 1/125 and 1/250. 
Crystallization and X-ray diffraction data 
collection — Crystallization assays were carried out by the 
sitting-drop vapor diffusion method using 96x2-well MRC 
plates (Innovadyne) and a Cartesian (Genomic Solutions) 
or a Phoenix (Art Robbins) nanodrop robot at the 
IBMB/IRB High-Throughput Automated Crystallography 
Platform. Crystallization plates were stored in Bruker 
steady-temperature crystal farms at 4ºC and 20°C. 
Successful hits were scaled up to the microliter range with 
24-well Cryschem crystallization dishes (Hampton 
Research). The best crystals of proabylysin appeared at 
20°C from equivolumetric drops containing protein 
solution (2mg/ml in buffer C) and 100mM MES, 200mM 
sodium/potassium phosphate, 2.6M sodium chloride, 
pH6.5 as reservoir solution. The best crystals of 
projannalysin were obtained at 4°C from drops containing 
protein solution (20mg/ml in buffer C) and 100mM Tris-
HCl, 200mM lithium sulfate monohydrate, 25% (w/v) 
polyethylene glycol 3,350, pH8.5 as reservoir solution at a 
2:1 ratio. Crystals were cryo-protected with successive 
passages through reservoir solution containing increasing 
concentrations of glycerol—up to 10 and 20% (v/v) for 
projannalysin and proabylysin, respectively. A heavy-ion 
derivative of projannalysin was prepared by soaking native 
crystals for 5min in reservoir solution containing 5mM 
mercury(II) acetate.  
Complete diffraction datasets were collected at 
100K from liquid-N2 flash-cryo-cooled crystals (Oxford 
Cryosystems 700 series cryostream) on a Pilatus 6M pixel 
and an ADSC Q315R CCD detector at beam lines ID29 
(proabylysin) and ID23-1 (native and derivative 
projannalysin), respectively, at the European Synchrotron 
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Radiation Facility (ESRF, Grenoble, France) within the 
Block Allocation Group “BAG Barcelona.” Crystals of 
proabylysin were primitive orthorhombic, with one 
molecule per asymmetric unit, whereas crystals of 
projannalysin were trigonal with two molecules per 
asymmetric unit. Diffraction data were integrated, scaled, 
merged, and reduced with programs XDS (55), and 
XSCALE (56) or SCALA (57), the latter within the CCP4 
suite of programs (58)(see Table 1). 
Structure solution and refinement — The structure 
of proabylysin was solved by single-wavelength 
anomalous diffraction by using the diffraction data to 1.6Å 
resolution of a crystal collected at the zinc K-edge peak 
wavelength, as inferred from a previous XANES 
fluorescence scan, which enabled program SHELXD 
(59,60) to identify the zinc ion present in the asymmetric 
unit. Subsequent phasing with this site using program 
SHELXE (60,61) and higher-resolved diffraction data to 
1.15Å resolution collected at a remote wavelength as a 
pseudo-native dataset yielded a suitable electron density 
map for chain tracing on a Silicon Graphics Octane2 
Workstation using the TURBO-FRODO program (62) and 
on a Linux-operated PC using the COOT program (63,64). 
Model building alternated with crystallographic refinement 
with program BUSTER (65), which included TLS 
refinement, until completion of the model. The final 
refinement was performed with SHELXL (61) and 
included anisotropic refinement of atomic displacement 
parameters. It comprised residues M1-V105 (superscripted 
residue numbering for proabylysin), one zinc ion, one 
glycerol molecule, and 147 solvent molecules (see Table 
1).  
The structure of projannalysin was solved by single-
wavelength anomalous diffraction by using the diffraction 
data to 2.4Å resolution of a crystal collected at the mercury 
LIII-edge peak wavelength, as determined from a previous 
XANES fluorescence scan, which enabled program 
SHELXD to find six mercury sites. Visual inspection of 
these sites on a graphic display with TURBO-FRODO 
enabled the identification of two clusters of three sites, 
which allowed the associated dimeric non-crystallographic 
symmetry operator to be derived. Subsequent phasing with 
these sites using program SHELXE and higher-resolved 
native diffraction data to 2.0Å resolution, followed by 
density modification with two-fold averaging with the DM 
program (66), yielded an electron density map suitable for 
model building, which proceeded as for proabylysin. 
Crystallographic refinement was performed with 
BUSTER. The final model of projannalysin comprised 
residues G-2-I110 (superscripted residue numbering in 
italics) of molecule A and thus included the N-terminal 
residues G-2 and P-1, which precede M1 as a result of the 
cloning strategy and TEV cleavage (see above). In 
addition, residues K7-I110 of molecule B plus seven 
glycerols, one Tris and two zinc cations, four sulfate and 
three chloride anions, and 194 solvent molecules 
completed the model of projannalysin (see Table 1).  
Figures were prepared with the CHIMERA program 
(67). Interaction surfaces (taken as the total surface area 
buried in a complex) were calculated with CNS taking a 
probe radius of 1.4Å (68). Structural superpositions were 
performed with the SSM routine (69) within COOT. 
Surface complementarity was computed with SC (70) 
within CCP4 with default parameters. Model validation 
was performed with MOLPROBITY (71) and the 
WHATCHECK routine of WHATIF (72). The final 
coordinates of proabylysin and projannalysin have been 
deposited with the PDB (access codes 4JIU and 4JIX, 
respectively). 
Structure-similarity analyses — The MAMMOTH 
program (73) was used with default parameters to search 
for proabylysin and projannalysin homologous structures 
in the PDB (74) as of 11/2012. Structural similarity 
searches were also carried out with the DALI program 
(http://ekhidna.biocenter.helsinki.fi/dali_server/start; (75)). 
 
RESULTS AND DISCUSSION 
 
Bioinformatics searches reveal minimal putative 
metallopeptidases — We performed bioinformatics 
searches to identify orthologs of M48 and M56 IMMPs 
containing only the CD by using the sequence stretch of 
BlaR1/MecR1 from S. aureus (family M56) contained 
between two predicted TMHs and encompassing the 
HEXXH zinc-binding motif (see “Experimental 
procedures” and Fig. 1). Three top hits were found, which 
were uncharacterized proteins from the thermophiles A. 
aeolicus, P. abyssi and M. jannaschii. They contained the 
zinc-binding motif and were closely related, aligning with 
28-31% pairwise sequence identity (Fig. 2a). With a size of 
105-110 residues and the absence of predicted signal 
peptides and transmembrane segments, they would 
represent a “minimal” scaffold for a soluble MP. A profile-
based sequence alignment against the MEROPS database 
revealed that these sequences were evolutionarily related to 
M56-IMMPs and also close to M48-IMMPs (Fig. 2b). 
Proteolytic assays suggest zymogenic forms — 
The three thermophilic proteins were recombinantly 
overexpressed in E. coli. The proteins from P. abyssi 
(proabylysin) and M. jannaschii (projannalysin) proved to 
be soluble and were readily purified to homogeneity. 
Conversely, the ortholog from A. aeolicus was insoluble 
under all expression conditions tested and no suitable 
refolding strategies could be found, and so was discarded. 
Full-length proabylysin and projannalysin were correctly 
folded as assessed by size-exclusion chromatography, 
which unambiguously revealed that they eluted as a 
monomer and dimer, respectively, at protein 
concentrations ranging from 0.1 to 2mg/ml for the former 
and 0.1 to 40mg/ml for the latter. Notably, proabylysin was 
stable for long periods only at a maximum concentration of 
∼0.6mg/ml at 20°C. Both proteins were inactive against a 
large battery of protein and peptide substrates (see 
“Experimental procedures”). As P. abyssi and M. 
jannaschii are hyperthermophilic organisms whose 
growing temperature and pressure can reach 95°C and 200 
atmospheres, respectively, we also performed activity 
assays with these two proteins at high temperature (up to 
80°C) and/or in the presence of chaotropic agents (urea and 
guanidinium hydrochloride) to mimic the physiological 
conditions. However, we did not observe any activity for 
these proteins under these conditions either (data not 
shown), strongly suggesting that they were zymogens, as 
indicated by structural studies (see following sections).  
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The structure of proabylysin indicates a novel 
intra-molecular mechanism of latency – The crystal 
structure of proabylysin was determined by single-
wavelength anomalous diffraction of the intrinsic zinc and 
refined with diffraction data to 1.15Å resolution (see 
“Experimental procedures”). The structure shows a 
compact globular, almost spherical shape ~35Å in 
diameter (Fig. 3a). A shallow active-site cleft is carved into 
the front surface of the molecule when viewed in standard 
orientation (44) and divides it into an upper, N-terminal 
sub-domain (NTS; M1-E68; superscripted proabylysin 
residue numbering) and a lower, C-terminal sub-domain 
(CTS; T69-V105). The NTS starts on the right top rear of the 
molecule in the form of an α-helix, hereafter referred to as 
the “backing helix” α1 (for nomenclature and extension of 
regular secondary structure elements, see Fig. 2a), which 
runs diagonally downwards and ends in a loop connecting 
α1 with the first strand β1 (Lα1β1) of a front, twisted 
three-stranded β-sheet (β1-β3). The top strands (β1 and β3) 
are parallel and the lowermost (β2), which creates an 
“upper rim” of the active-site cleft, is antiparallel to the 
cleft and, thus, to any substrate bound to it. Preceding the 
latter strand is the “bulge-edge segment” (L26-I30), which 
contributes to shaping the top of the cleft on its primed side 
(for cleft and substrate sub-site nomenclature, see (44,76)). 
After β3, a short 310-helix (η1; the “linking helix”) at the 
right top of the molecule links the sheet with the “active-
site helix” α2, which contains the short zinc-binding 
consensus sequence H60EXXH64 (see below). The helices 
and the sheet of the NTS contribute through their inner 
surfaces to an internal hydrophobic core, which traverses 
the entire protein moiety and glues the structure together. 
After α2, the polypeptide chain enters the CTS through 
Lα2α3, which leads to the “glutamate helix” α3. The latter 
is termed thus due to its topological equivalence with a 
similar helix in gluzincins (see below), and it lies in a 
horizontal plane that is roughly parallel to that of helix α2 
but with the helix axis vertically rotated backwards by 
~50º, so that α3 ends with V83 at the back molecular 
surface. At F84, the chain turns frontwards and, after a loop 
that forms the bottom of the molecule (P85-R86), opens out 
into the “C-terminal helix” α4, which runs obliquely and 
creates the lower right part of the molecule (Fig. 3a). The 
last residue of α4, L100, resides in a hydrophobic pocket 
created by the side chains of A45, I30, I57 and I96, which 
feature the rightmost end of the internal hydrophobic core 
of the NTS (Fig. 3a). From Q101 onwards, the polypeptide 
chain enters the primed side of the active-site cleft in the 
extended conformation of—but reverse orientation to—a 
true peptidic substrate and reaches the zinc site with the C-
terminal carboxylate of V105. This C-terminal tail 
establishes inter-main chain hydrogen bonds with residues 
from the bulge-edge segment and the start of upper-rim 
strand β2 (N103 O – N30 N, 2.87Å; V105 N – A31 O, 2.92Å).  
The catalytic zinc ion resides at the bottom of the 
active-site crevice, somewhat displaced from half way 
towards the non-primed side of the cleft (Fig. 3a). The 
metal is coordinated in a tetrahedral fashion by the Nε2 
atoms of the two histidines of the consensus sequence, H60 
(2.02Å apart) and H64 (2.00Å), one of the two C-terminal 
carboxylate oxygens of V105 (2.02Å), and the Nε2 atom of 
H72 (2.02Å apart), which is provided by Lα3α4 two 
positions ahead of the start of the glutamate helix α4. The 
other carboxylate oxygen of V105 is further way from the 
metal (2.69Å) and in a geometrically unfavorable 
conformation for binding (Fig. 3a). By contrast, this 
oxygen contacts in a distorted bidentate manner the two 
carboxylate oxygens of the general base/acid glutamate E61 
(2.68Å and 3.28Å apart), thus indicating that either of the 
carboxylate groups must be in protonated state.  
The insertion of the C-terminal tail also provides 
information on the distinct sub-sites on the primed side of 
the cleft. M104 nestles into what is most likely the S1’ sub-
site of the cleft (cleft and substrate sub-sites in bold), 
which is usually the major determinant for specificity in 
MPs (44). The methionine side chain is present in double 
conformation and the surrounding residues give rise to a 
site that is wide and hydrophobic, thus suggesting that 
mature abylysin could easily accommodate bulky 
hydrophobic residues in P1’, as observed in the otherwise 
unrelated matrix metalloproteinases, snapalysins, and 
ADAMs/adamalysins, which are metzincins (77-79). The 
S1’ pocket is framed at its back by residues from the start 
of the active-site helix (Y56, I57, and H60), and at its right 
and bottom by residues from the C-terminal helix (E93 and 
I96). The antepenultimate residue of the tail, N103, possibly 
at P2’, points towards the bulk solvent, suggesting that this 
site is not relevant for specificity as long as the extended 
conformation of the substrate is maintained. R102, in turn, 
probably occupies S3’, which would be shaped by the side 
chains of I30, A45, and L100, and the main chain of the 
bulge-edge segment at P25-I30. The guanidinium group of 
R102 establishes two hydrogen bonds with the main-chain 
carbonyl oxygens of L26 and S29 (2.50Å and 2.92Å apart, 
respectively), and a double salt bridge with D43 at the end 
of Lβ3η1. The R102 Nη1 and Nη2 atoms are, respectively, 
3.01Å and 3.02Å apart from the carboxylate oxygens of 
the aspartate. As found for M104 in S1’, R102 fits neatly into 
the potential S3’ site, suggesting that mature abylysin could 
have a preference for arginine in P3’. A look at the putative 
non-primed side of the cleft, in turn, suggests that V105 is in 
S1. It has its side chain pointing towards the bulk solvent, 
thus suggesting that any residue of a potential substrate 
could be found in P1. Upstream of P1, a substrate could be 
accommodated in a rather shallow S2 or S3 site, putatively 
framed by the side chains of V33, F35, H64, L65 and S70 (Fig. 
3a). 
Overall, the structure of the globular part of 
proabylysin spanning M1-L100 indicates a competent MP 
moiety, active-site cleft, and metal-binding site—including 
the pivotal glutamate general base/acid required for 
catalysis—as found in active enzymes of this class (see 
also below). By contrast, the insertion of the C-terminal 
tail into the active-site cleft in the reverse orientation of a 
substrate, thus blocking structural elements essential for 
catalysis and access of true substrates, provides a structural 
explanation for the lack of hydrolytic activity of the protein 
as it would actually correspond to a zymogen. The latency 
mode has been hitherto unseen for structurally-
characterized MPs, which are normally kept latent by N-
terminal pro-domains or pro-peptides, as in astacin (80), 
meprin β (81), fragilysin (52),  funnelin carboxypeptidases 
(82), matrix metalloproteinases (77), ADAMs/adamalysins 
(78), and thermolysin (83). Accordingly, the present 
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structure represents a novel mechanism of intra-molecular 
latency maintenance in MPs. 
The structure of projannalysin suggests a novel 
inter-molecular mechanism of latency — The crystal 
structure of projannalysin was determined by single-
wavelength anomalous diffraction of a mercury derivative 
and refined with diffraction data to 2.0Å resolution (see 
“Experimental procedures”). In one of the two molecules 
found in the asymmetric unit of the crystal—molecule A—
the N-terminal stretch of projannalysin protrudes away 
from the molecular moiety and is defined from the first 
residue of the construct, G-2 (superscripted projannalysin 
residue numbering in italics), to N4, due to an interaction 
with a crystallographic neighbor (Fig. 3b, left, in tan). The 
final electron density is somewhat weaker at E5 and N6, but 
becomes fully defined again from K7 onwards, which is the 
first residue of the globular moiety. By contrast, in 
molecule B the polypeptide chain is defined from K7 
onwards only (Fig. 3b, right, in turquoise).  
In accordance with a 31% sequence identity (see 
Fig. 2a), projannalysin and proabylysin exhibit a very 
similar overall shape and practically overlapping chains 
from the beginning of helix α1 to the end of helix α4 (M1-
L100 of proabylysin and D9-L109 of projannalysin; Z-value 
according to the DALI program of 16.0; rmsd of 1.5Å). All 
the regular secondary structure elements are conserved 
with the sole exception of proabylysin 310-helix η1, which 
has an extra residue in projannalysin and becomes here an 
α-helix (termed α1’, K52-N57; see Figs. 2a and 3b,c). After 
L109, the last residue of projannalysin projects away from 
the molecular body, pointing in the opposite direction to 
the proabylysin C-terminal tail and becoming engaged in 
binding of a neighboring molecule (see below and Fig. 
3b,c). 
Consistent with the dimeric behavior observed in 
size-exclusion chromatography, projannalysin is also a 
dimer in the crystal structure (Fig. 3b, right). Two 
molecules interact through an interaction surface of 
~1,980Å2, which is above the range generally described for 
protein-protein complexes (1,250-1,750Å2; (84)), and 
indicates that such a dimer is likely to occur in vivo. The 
interaction surface shows a surface complementarity 
(Sc=0.67) that lies within the range reported for 
antibody/antigen interfaces (0.64-0.68; (70)). The 
interaction is nearly symmetric and results from 32 inter-
molecular contacts (<4Å), among them nine hydrogen 
bonds and hydrophobic interactions between seven 
molecule A and six molecule B residues (Fig. 3d). 
Participating segments include Lβ1β2, Lβ3α1’, α2, Lα2α3, 
and α4 of either molecule (Fig. 3d), and the catalytic metal 
ions are 24Å apart. Most noteworthy is the crosswise 
interaction between the active-site of one molecule and the 
C-terminal helix α4 of the other (Fig. 3b,c). The latter 
blocks access to the cleft and provides, thus, the structural 
explanation for the lack of hydrolytic activity of 
projannalysin. Like proabylysin, it is a zymogen but by 
contrast latency is exerted crosswise inter-molecularly by 
the swap of a C-terminal α-helix. This also entails 
significant differences in the zinc-binding site. In 
projannalysin, the metal is surrounded by a distorted 
octahedral hexa-coordination sphere, which is rather 
unusual for zinc according to MESPEUS database 
(http://mespeus.bch.ed.ac.uk/MESPEUS_10; see Table 2 
in (85)). Protein ligands equivalent to proabylysin are the 
Nε2 atoms of H69 (2.1/2.0Å apart from the metal in 
molecules A/B, respectively) and H73 (2.1/2.1Å) of the 
zinc-binding sequence, and H81 of Lα2α3 (2.1/2.1Å). In 
addition, the metal is distinctly bound by a solvent 
molecule (2.2/2.1Å apart) and, in molecule A, a Tris 
molecule through its amino (2.2Å) and one of its hydroxyl 
groups (1.9Å) in a bidentate fashion. In molecule B, this 
ligand is replaced by a glycerol, two of whose hydroxyl 
oxygens are 2.1 and 2.2Å apart from the metal, 
respectively. The solvent molecule and H73 Nε2 are in 
apical positions and the other four ligands in a plane with 
the metal (Fig. 3c). Accordingly, and in contrast to 
proabylysin, the two carboxylate oxygens of the C-
terminus (here, I110 of the neighboring molecule) are far 
from the zinc ion (4.1-4.2Å). Instead, they contact the 
carboxylate of the general base/acid glutamate, E70 
(2.6/2.5Å in molecule A/B, respectively) plus the zinc-
binding hydroxyl of the Tris (glycerol) molecule (both 
2.6Å apart), and the zinc-bound water (2.7/2.6Å), 
respectively. This architecture indicates that either of the 
carboxylate groups of E70 or L109 must be in protonated 
state, as found in proabylysin (see above). The structure of 
the dimeric zymogenic complex further reveals that the S1’ 
pocket is partially occupied by the side chain of the last 
residue, I110, instead of the penultimate residue as seen in 
proabylysin. The pocket is very similar in depth and 
hydrophobicity in both zymogens and framed in 
projannalysin by A39 (A31 in proabylysin), I38 (I30), I66 (I58), 
Y65 (Y56), I105 (I96), L109 (L110), and E102 (E93).  
As for proabylysin, the globular part of 
projannalysin spanning D9-L109 indicates a competent fold 
of catalytic moiety, active-site cleft, metal-binding site, 
and general base/acid glutamate, as usual for active MPs 
(see also below). By contrast, the insertion of the C-
terminal part of helix α4 into the active-site of a neighbor 
contributes to another novel C-terminal latency mechanism 
for this type of enzymes, which is homodimeric and occurs 
crosswise.  
Activation trials point to an intricate mechanism 
of peptidase activation — To provide insight into the 
mechanism of activation of these MPs, we attempted to 
subject them to limited proteolysis to remove the 
zymogenic segments by assaying them with a collection of 
standard serine- and metalloproteinases, which only 
yielded intact proteins or resulted in complete degradation 
(data not shown). We thus designed a range of constructs 
lacking C-terminal residues of proabylysin and 
projannalysin. Proabylysin constructs in which the last five 
residues were sequentially deleted showed dramatically 
decreasing expression and solubility levels when compared 
with the wild-type protein, thus precluding purification 
and/or functional assays for most of the constructs. Only 
those lacking the last one and two residues, respectively, 
could be purified. However, they showed a significantly 
decreased melting temperature (Tm) in a thermofluor assay 
(85 and 65°C, respectively; see “Experimental 
procedures”) when compared with that of the wild type 
(95°C), which is indicative of structurally labile and 
inactive forms. Assays of fusion constructs of C-terminal 
truncations with N-terminal GST or streptavidin-tag, which 
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rendered only soluble aggregates as assessed by size-
exclusion chromatography (data not shown) were also 
unsuccessful. Similar negative results were obtained with a 
projannalysin mutant lacking the last five residues (data 
not shown), which theoretically should avoid inhibition but 
not affect the overall protein moiety as inferred from the 
crystal structure (see above). In conclusion, we failed to 
obtain active abylysin and jannalysin. This strongly 
suggests that both proteins likely need the assistance of a 
specific protease for activation and/or a conformational 
change that is brought about in the intracellular living 
environment but that we were unable to reproduce in vitro. 
Nevertheless, the possibility that these proteins are inactive 
ancestors of metallopeptidases cannot be ruled out. 
Proabylysin and projannalysin are structurally 
related to gluzincins — Thermolysin from Bacillus 
thermoproteolyticus was the first metalloendopeptidase 
structurally characterized, back in 1972 (86), and is the 
founding member of the gluzincins ((41,42); see also Table 
2 in (44)). Superposition of both proabylysin and 
projannalysin onto thermolysin reveals that the polypeptide 
chains are very similar along almost the entire structure of 
the former (M1-K99) and V71-P195 of the latter (Fig. 4a,b), 
including the position of the N- and C-termini of the 
superposed parts and all regular secondary structure 
elements, with the exception of the linking and C-terminal 
helices, which are replaced by loops in the Bacillus 
enzyme. This similarity is reflected by a DALI Z-value of 
3.5, an rmsd of 2.9Å, 83 topologically aligned residues but 
only 8% sequence identity. In particular, the active-site and 
glutamate helices overlap despite being, respectively, one 
and two turns shorter in the present structures (Fig. 4a; see 
also preceding sections). Overall, these two helices are the 
major characteristic features of gluzincins and provide the 
three protein zinc ligands—usually two histidines and a 
glutamate (H142, H146, and E166 in thermolysin). This 
shortening of the present structures entails that the third 
protein zinc ligand—a histidine—is found in the loop 
preceding the glutamate helix. Nevertheless, the position of 
this third ligand is practically the same and the Cα atoms 
of proabylysin H72 and thermolysin E166 are only 1.4Å 
apart (Fig. 4b). In addition, the three-stranded β-sheets and 
the backing helices fit well on top of each other in both 
structures, both in sequence, position and orientation, 
although they are linked by longer loops in thermolysin 
(Fig. 4a). A further feature of gluzincins is the “Ser/Gly-
turn” within the glutamate helix, downstream of the metal-
binding glutamate, which contains a residue—usually a 
serine or a glycine—whose side chain is found 
immediately below the metal-binding site (82). This 
structural element is reminiscent of the “Met-turn”, which 
has a strictly conserved methionine and is characteristic of 
metzincins (51). Such a Ser/Gly-turn is also present in 
proabylysin and projannalysin, centered on a phenylalanine 
(F76 and F85, respectively), which is also found in the A. 
aeolicus protein (Fig. 2a). In general, structurally 
characterized gluzincins are much larger than the minimal 
core found in proabylysin and projannalysin: thermolysin 
spans 316 residues and cowrin metallocarboxypeptidases, 
which also show the aforementioned structural similarity, 
span ~500-700 (82,86). In particular, both thermolysins 
and cowrins possess a downstream “tyrosine helix” below 
the glutamate helix (82).  
Another structurally characterized gluzincin family 
consists of leukotriene A4 hydrolase (PDB 3B7S; (87)) 
and related metalloaminopeptidases such as cold-active 
aminopeptidase (PDB 3CIA; (88)), endoplasmic reticulum 
aminopeptidase 1(PDB 3QNF, 3MDJ; (89,90)), tricorn 
interacting factor F3 (PDB 1Z5H; (91)), M1 alanyl-
aminopeptidase (PDB 3EBI; (92)), and aminopeptidase N 
(PDB 2HPO; (93)). Like cowrins (82), these are large 
multi-domain enzymes spanning ~600-950 residues that 
contain an inserted CD bearing a greater resemblance to 
proabylysin and projannalysin than that of thermolysin 
(DALI Z-values between 7.2 and 6.4). They even include 
the linking and C-terminal helices, although the latter is 
rotated frontwards by ~45-90 degrees. This family has a 
glutamate as the third zinc ligand and a threonine or 
alanine in the Ser/Gly-turn.  
Overall, the close general similarity of proabylysin 
and projannalysin to distinct active gluzincin families 
strongly suggests that the globular parts of these two 
zymogens are in an overall competent conformation (see 
also preceding sections) and that latency is exerted through 
C-terminal segments by sterically blocking access to 
preformed CDs. Accordingly, the thermophylic proteins 
studied here would represent a minimal structural and 
functional core of the gluzincin clan, and, as such, we 
propose the family name “minigluzincins” for them. The 
fact that minigluzincins have a histidine instead of a 
glutamate as third zinc ligands and a phenylalanine in the 
Ser/Gly-turn reflects variability among gluzincins that is 
also observed in metzincins, which generally have a 
histidine as the third zinc ligand, although snapalysins and, 
possibly, thuringilysins, have an aspartate (94).  
Minigluzincins are models for catalytic domains 
of M48 and M56 metallopeptidases — Despite the 
obvious structural similarity with the aforementioned 
gluzincins, automated structure-similarity searches of 
proabylysin and projannalysin against the PDB identified 
three other, more closely related structures: a putative 
peptidase from Geobacter sulfurreducens (PDB 3C37; 
DALI Z-score 7.4; rmsd 3.1Å; 98 aligned residues; 13% 
sequence identity); a fragment of HtpX from Vibrio 
parahaemolyticus (PDB 3CQB; DALI Z-score 6.8; rmsd 
2.1Å; 71 aligned residues; 15% sequence identity); and 
human FACE1 (PDB 4AW6; (40); DALI Z-Score 4.6; 
rmsd 2.8Å; 96 aligned residues; 18% sequence identity; 
see Fig. 4c,d). The latter is very similar to its yeast 
ortholog Ste24p (PDB 4IL3; (39)). PDB entry 3C37 was 
deposited with the PDB by a structural genomics 
consortium but not published. It corresponds to a soluble 
253-residue protein tagged by the depositors as an M48-
family peptidase, although it is not an IMMP. It is a non-
functional protein whose putative catalytic metal ion is 
bound in a canonical manner by three residues provided by 
an active-site and a glutamate helix, and also by a fourth 
histidine ligand coming from a second protein chain, so 
that the cleft is blocked. In the absence of further data and 
a publication, crystallization artifacts cannot be ruled out in 
this case. PDB entry 3CQB, in turn, is an artificial 
fragment between two TMHs of a Vibrio relative of M48-
family member HtpX from E.coli, which was likewise 
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deposited by a structural genomics consortium and not 
published. It lacks a functional active-site cleft and metal-
binding site, and could potentially correspond to the NTS 
of the CD of this M48 family member. Finally, PDB 
entries 4AW6 and 4IL3 correspond to human and yeast 
FACE1/Ste34p, the only two true IMMPs currently 
available for their 3D structures in addition to S2P MP 
from M. jannaschii (36). The latter belongs to family M50, 
is not a gluzincin (see Fig. 2 in (44)), and is only very 
distantly related to proabylysin (PDB 3B4R; DALI Z-
Score 1.2; rmsd 3.5; 51 aligned residues; 10% sequence 
identity) and its structural relatives. Human and yeast 
FACE1/Ste24p represent the only M48-IMMPs 
structurally characterized to date. Further entries that are 
similar to minigluzincins are two closely related hypothetic 
proteins reported by structural genomics consortia: ybeY 
from E. coli (PDB 1XM5; (95)) and AQ-1354 from A. 
aeolicus (PDB 1OZ9; (96)), for which no function has 
been characterized. These are single-domain proteins of 
~150 residues that contain a third metal-binding histidine 
and a methionine and phenylalanine, respectively, in the 
Ser/Gly-turn. They possess a linking helix but, despite 
rather large DALI Z-scores when compared with 
proabylysin (6.9 and 7.6, respectively), they lack the C-
terminal helix of minigluzincins and have additional 
regular secondary structure elements inserted into the basic 
scaffold. 
Superposition of proabylysin and projannnalysin 
onto the putative peptidase of G. sulfurreducens, human 
FACE1, and truncated HtpX, reveals that all the common 
regular secondary structure elements shared by 
minigluzincins with thermolysin and other gluzincins are 
also found in the aforementioned M48-related structures. 
Taken together, this ascribes M48-IMMPs to the gluzincin 
clan of MPs. In addition, the closer structural similarity of 
minigluzincins to the aforementioned three M48-like 
structures than to other gluzincins (see Z-scores above) is 
reflected by the fact that the linking helix (in PDB 3C37, 
3CQB, and 4AW6) and the C-terminal helix (in PDB 3C37 
and 4AW6), absent in thermolysin and cowrins, are found 
in both groups (see Figs. 4c,d and 5). Furthermore, in the 
absence of structural information on the IMMP part of 
M56 proteins, independent secondary-structure prediction 
of full-length BlaR1/MecR1, together with predictions for 
M48 HtpX and Oma1 and the experimental structures of 
the two minigluzincin zymogens and their three structural 
relatives, reveals that the CDs are most likely very similar 
in M48- and M56-IMMPs. This is further supported by the 
fact that minigluzincins were actually found in a search 
with BlaR1/MecR1 sequences and by evolutionary studies 
(see above), which indicate that minigluzincins are even 
closer to M56- than to M48-IMMPs (Fig. 2b).  
 
CONCLUSIONS 
 
The present work describes a novel family of 
minimal ~100-residue soluble MPs, the minigluzincins, 
which evince unique zymogenic structures that are 
maintained in their inactive state by intra- or inter-
molecular C-terminal segments. The minigluzincins share 
very similar chain traces with thermolysin and other 
gluzincins such as leukotriene A4 relatives and cowrins, 
but bear even higher similarity with M48 and M56 
IMMPs, thus representing a minimal scaffold for the CDs 
of a large cohort of integral-membrane proteins. The 
characterizing feature of the M48- and M56-family CDs is 
a compact domain containing a backing helix, a three-
stranded β-sheet, a linking helix, an active-site helix 
providing two metal ligands, a glutamate helix providing a 
third metal ligand and a Ser/Gly-turn, as well as a C-
terminal helix (Fig. 5). Into this minimal common scaffold, 
each specific family member has inserted large upstream, 
internal and downstream structural elements, including 
TMHs, to yield the specific functionality as membrane-
embedded MPs. Altogether, structural knowledge of 
minigluzincins may be helpful in the construction of 
shorter soluble variants of IMMPs and thus facilitate the 
design of drugs to modulate their function. 
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Dabcyl, p-dimethyl(aminophenyl)azobenzoate; Dap, L-diaminopropionyl; dnp, 2,4-dinitrophenylamino; Edans, 2-
aminoethylamino-1-naphthalene sulfonate; FACE1, farnesylated-protein converting enzyme 1; GST, glutathione-S-
transferase; IM, integral(-)membrane; IMMP, IM metallopeptidase; Mca, 7-methoxycoumarin-4-acetyl; MP, 
metallopeptidase; NTS, N-terminal sub-domain; Nva, norvaline; ONp, p-nitrophenyl ester; PDB, Protein Data Bank at 
www.pdb.org; pNA, p-nitroanilide; S2P, site-2 proteinase; TEV, tobacco-etch-virus; TMH, transmembrane helix; and 
UP, UniProt sequence database (www.uniprot.org) access code. 
 
FIGURE LEGENDS 
 
Figure 1. Transmembrane topologies of selected M48 and M56 integral-membrane metallopeptidases. 
The predicted transmembrane topologies of Escherichia coli HtpX (UP P23894), Saccharomyces cerevisiae Oma1 (UP 
P36163), and Staphylococcus aureus BlaR1 (UP P18357) were obtained using the TOPCONS program (99) and 
represented using the TOPO2 server (http://www.sacs.ucsf.edu/TOPO2/). The topology of human FACE1 (UP O75844) 
was derived from the experimental coordinates (PDB 4AW6). The N- and C-terminal residues, as well as the flanking 
transmembrane residues, are labeled. FACE1 is located in the human endoplasmic reticulum and Golgi apparatus 
membrane, HtpX in the bacterial cell inner membrane, Oma1 in the mitochondrial inner membrane, and BlaR1 in the 
bacterial cell membrane. The zinc-binding signature HEXXH residues are shown in black circles as well as the third 
protein ligand of FACE1, a glutamate. The segments approximately corresponding to the catalytic domains are framed 
where known or predictable. 
Figure 2. Bioinformatics studies of the target proteins. (A) Structure-based sequence alignment of, top to 
bottom, Pyrococcus abyssi UP Q9V1Y2, Aquifex aeolicus UP O66407, and Methanocaldococcus jannaschii UP 
Q57587 performed using the MULTALIN program (100) and represented using the ESPRIPT server 
(http://espript.ibcp.fr; (100)). Residues with 100%, 75%, and 50% identity are highlighted through red, orange, and 
yellow background, respectively. The sequence identities to each protein (in %) with the other two proteins (top to 
bottom) are shown at the beginning of the second alignment block. Numbering and regular secondary structure elements 
correspond to P. abyssi UP Q9V1Y2 (top) and M. jannaschii UP Q57587 (bottom). (B) Sequence-based phylogenetic 
tree of the three sequences of (A) and 69 homologous sequences from MEROPS database represented by their UniProt 
codes. The tree shows three major groups including HtpX-/HtpX-2-like proteins of family M48 (in blue), 
BlaR1/MecR1- or PenR1-like proteins of family M56 (in green), an unassigned member of family M48 (in magenta), 
and the three sequences of (A) in red. The tree revealed another orthologous sequence from M. jannaschii (UP 58610) 
not analyzed in the present work. The scale bar represents PHYML branch length. 
Figure 3. Structures of proabylysin and projannalysin. (A) Cross-eye stereo ribbon-plot of proabylysin in 
standard orientation (44), with coils, strands (labeled β1-β3, see also Fig. 2a) and helices (α1-α4 and η1) in pale pink, 
magenta, and pale purple, respectively. Selected residues are shown for their side chains as sticks with pink carbons and 
labeled, as is the N-terminus of the protein. The C-terminal segment running across the cleft (Q101-V105) is depicted as a 
stick model with gray carbons. (B) Superposition of the proabylysin (pink) and projannalysin (tan) monomers, whose 
termini are labeled. For both structures, the metal-binding residues, the general base/acid glutamate and the Ser/Gly-
turn phenylalanine are depicted as sticks with carbons colored as the respective ribbons (left panel). Structure of the 
projannalysin dimer in standard orientation (i.e. as in (A)), with one monomer in tan and the other in aquamarine, and 
after a horizontal 65º-rotation, which depicts the view along the non-crystallographic twofold axis shown as a red 
ellipse (right panel). (C) Cross-eye stereo ribbon-plot of projannalysin in standard orientation, with coils, strands 
(labeled β1-β3, see also Fig. 2a) and helices (α1, α1’, and α2-α4) in tan, orange, and brown, respectively. Selected 
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residues, as well as a Tris molecule coordinating the metal (yellow sphere) and a glycerol at the dimer interface, are 
shown as sticks with tan carbons and labeled in black. Three waters are shown as red spheres. The C-terminal segment 
(E102-I110) of the symmetry-related molecule in the dimer is shown as a stick model with carbons and labels in turquoise. 
(D) Close-up view in cross-eye stereo of the two projannalysin monomers displayed in Fig. 3b (right panel) superposed 
with the respective semi-transparent Connolly surfaces. The side chains of the residues involved in dimerization are 
shown as yellow and blue sticks, respectively, for molecules A and B.  
Figure 4. Structural similarities of miniglutzincins. (A) Cross-eye stereo plot depicting the superposition of 
proabylysin and Bacillus thermoproteolyticus thermolysin (PDB 4TLN; (101)) as ribbons colored in pale pink, 
magenta, and pale lilac (proabylysin) and yellow, light green, and dark green (thermolysin) for the coils, strands, and 
helices of the common stretches, respectively, whose ends are highlighted by orange arrows (M1-K99 of proabylysin and 
V71-P195 of thermolysin). The orientation corresponds to that of the standard orientation of MPs (44) as in Fig. 4a. The 
corresponding zinc ions are shown as magenta and green spheres, respectively. The remaining 70-residue N- and 121-
residue C-terminal stretches of thermolysin are shown in white. The characteristic calcium ions of thermolysin have 
been omitted for clarity. (B) Close-up view of (A) in cross-eye stereo depicting the metal-binding sites of proabylysin 
and thermolysin. The residues of the HEXXH sequence are shown for their side chains (in pink for proabylysin [H60, E 
61, and H64] and in green for thermolysin [H142, E143, and H146]). In addition, the respective downstream third metal-
binding residues (H72 of probabylysin and E166 of thermolysin; pinpointed by a blue arrow) and the residue of the 
Ser/Gly-turn (F76 of proabylysin and S169 of thermolysin; pinpointed by a red arrow) are depicted. (C) Superposition of 
proabylysin and M48-family human FACE1 protein (PDB 4AW6) in two views resulting from a 90-degree ccw in-
plane rotation of the orientation in Fig. 4a (left panel) and a subsequent vertical 180-degree rotation (right panel). The 
structurally equivalent parts and the catalytic metal ions are displayed in hot pink (proabylysin) and green (FACE1), the 
remaining parts of FACE1 are shown as a white coil. (D) Close-up view in cross-eye stereo of (C; left) after a 90-degree 
cw in-plane rotation, i.e. in standard orientation, showing only the common domains (M1-Q101 of proabylysin and K233-
G343+E415-N442 of FACE1). Coils, strands, and helices are shown, respectively, in pink, magenta, and hot pink 
(proabylysin) and in yellow, green, and light green (FACE1). The catalytic metal, the residues engaged in metal 
binding, and the general base/acid glutamate of each structure (H60, E 61, H64, and H72 of proabylysin and H335, E336, 
H339, and E415 of FACE1) are shown for their side chains with pink and green carbons, respectively. Orange arrows 
pinpoint the N- and C-termini of the common structure parts. Read arrows pinpoint the positions between the second 
and third zinc ligands, at which FACE1 has two of its TMHs inserted (segment H344-F414). These are actually a 
continuation of the active-site and glutamate helices. Black arrows indicate the residues flanking the disordered segment 
in FACE1 (E286-K321), which coincides with proabylysin linking helix η1. A blue arrow highlights the position of the 
Ser/Gly-turn residue (F76 in proabylysin and A418 in FACE1). 
Figure 5. Common topology of minigluzincins and selected M48 and M56 metallopeptidases. The actual 
regular secondary structure elements of the experimental structures of proabylysin (UP Q9V1Y2; this work), 
projannalysin (UP Q57587; this work), G. sulfurreducens M48-like peptidase (UP Q74D82; PDB 3C37), human 
FACE1 (UP O75844; PDB 4AW6), and a truncated form of V. parahaemolyticus HtpX containing only its N-terminal 
sub-domain (UP Q87QN1; PDB 3CQB) are represented with dark green rods (helices) and dark purple arrows (strands) 
with the residues flanking each secondary structure element. In addition, the predicted regular secondary structure 
elements of E. coli HtpX C-terminal sub-domain (UP P23894), yeast Oma1 (UP P36163), and S. aureus BlaR1 (UP 
P18357) are represented with light green rods (helices) and light purple arrows (strands). The protein numbering, the 
HEXXH motif, the third zinc binding residue, the Ser/Gly-turn residue, and the transmembrane segments (TM) taken 
either from the experimental structures or the predictions are indicated by either regular or italic letters, respectively.
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Table 1. Crystallographic data. 
 Pyrococcus abyssi proabylysin (UP Q9V1Y2) Methanocaldococcus jannaschii projannalysin (UP Q57587) 
 
Dataset 
 
Space group 
Cell constants (a, b, c, in Å) 
Wavelength (Å) 
No. of measurements / unique reflections 
Resolution range (Å) (outermost shell) b 
Completeness [/ Anom. completeness] (%) 
Rmerge d 
Rr.i.m. (= Rmeas) d [/ Rp.i.m. d] 
Average intensity (<[<I> / σ(<I>)]>) 
B-Factor (Wilson) (Å2) / Aver. multiplicity 
Resolution range used for refinement (Å) 
No. of reflections used (test set) 
Crystallographic Rfactor (free Rfactor) e 
No. of protein atoms / solvent molecules / 
     neutral ligands / 
     ionic ligands 
Rmsd from target values 
     bonds (Å)  /  angles (°) 
     Average B-factors for protein atoms (Å2) 
Main-chain conformational angle analysis c
 
     Residues in  
     favored regions / outliers / all residues 
 
Native 
 
P212121 
34.62, 44.66, 72.00 
0.9540 
495,316 / 40,510 
44.7 – 1.15 (1.21 – 1.15) 
100.0 (100.0) 
0.072 (0.892) 
0.075 (0.934) / 0.021 (0.272) 
18.5 (3.4) 
11.0 / 12.2 (11.3) 
∞ – 1.15 
39,668 (778) 
0.147 (0.192) 
900  /  147 / 
1 (CH2OH)2CHOH / 
1 Zn2+ 
 
0.014  /  2.24 
17.7 
 
 
103 / 0 / 103 
 
Zinc a 
(absorption peak) 
P212121 
34.68, 44.90, 72.23 
1.2821 
99,212 / 15,317 
44.9 – 1.60 (1.69 – 1.60) 
98.9 (92.9) / 97.3 (86.6) 
0.059 (0.374) 
0.069 (0.453) / 0.035 (0.250) 
15.5 (4.5) 
18.2 / 6.5 (5.2) 
 
Native 
 
P3121 
76.59, 76.59, 124.32 
0.9790 
305,164 / 29,001 
45.4 – 2.00 (2.05– 2.00) 
99.1 (98.6) 
0.042 (0.851) 
0.044 (0.910)  
30.3 (2.8) 
49.4 / 10.5 (7.9) 
∞ – 2.00 
28,924 (751) 
0.183 (0.213) 
1,815  /  194 / 
7 (CH2OH)2CHOH / 
1 C(CH2OH)3NH3+, 2 Zn2+, 3 Cl-, 4 SO42-  
 
0.009  /  0.96 
54.9 
 
 
211 / 0 / 212 
 
Mercury a 
(absorption peak) 
P3121 
76.60, 76.60, 124.76 
1.0044 
179,641 / 31,910 
89.1 – 2.40 (2.46– 
2.40) 
99.6 (96.6) 
0.048 (0.541) 
0.054 (0.615)  
24.2 (3.0) 
54.4 / 5.6 (4.4) 
 
 
 
 
 
a Friedel-mates were treated as separate reflections. b Values in parentheses refer to the outermost resolution shell. c According to MOLPROBITY (71).
 
d Rrmerge = ΣhklΣi |Ii(hkl) - <I(hkl)>| / ΣhklΣi Ii(hkl); Rr.i.m.= Σhkl(nhkl /[nhkl-1])1/2 Σi |Ii(hkl) - <I(hkl)>| / ΣhklΣi Ii(hkl); Rp.i.m.= Σhkl(1/[nhkl-1])1/2 Σi |Ii(hkl) - <I(hkl)>| / ΣhklΣi Ii(hkl), where Ii(hkl) is the i-th intensity measurement 
and nhkl the redundancy of reflection hkl—including symmetry-related reflections—and <I(hkl)> its average intensity. Rr.i.m. (alias Rmeas) and Rp.i.m. are improved multiplicity-weighted indicators of the quality of the data, 
the redundancy-independent merging R factor and the precision-indicating merging R factor. The latter is computed after averaging over multiple measurements (for details, see (97,98)).  
e Crystallographic Rfactor = Σhkl ||Fobs| - k |Fcalc|| / Σhkl |Fobs|, where k is a scaling factor, and Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively. This factor is calculated for the working-set 
reflections; free Rfactor, same for a test-set of reflections (>500) not used during refinement.
 
 





